173 related articles for article (PubMed ID: 10064157)
21. Isolation of a tripeptide from a random phage peptide library that inhibits P1,P4-diadenosine 5'-tetraphosphate binding to its receptor.
Liu G; Bryant RT; Hilderman RH
Biochemistry; 1996 Jan; 35(1):197-201. PubMed ID: 8555174
[TBL] [Abstract][Full Text] [Related]
22. Functional coupling between adenosine A
Odagaki Y; Kinoshita M; Ota T; Meana JJ; Callado LF; Matsuoka I; García-Sevilla JA
Purinergic Signal; 2018 Jun; 14(2):177-190. PubMed ID: 29492786
[TBL] [Abstract][Full Text] [Related]
23. Pharmacological characterization of type 1alpha metabotropic glutamate receptor-stimulated [35S]-GTPgammaS binding.
Akam EC; Carruthers AM; Nahorski SR; Challiss RA
Br J Pharmacol; 1997 Jul; 121(6):1203-9. PubMed ID: 9249258
[TBL] [Abstract][Full Text] [Related]
24. Binding and internalization of p1,p4-diadenosine 5'-tetraphosphate by bovine aortic endothelial cells.
Hilderman RH; Fairbank AT
Biochimie; 1999 Mar; 81(3):255-60. PubMed ID: 10385007
[TBL] [Abstract][Full Text] [Related]
25. Functional coupling between metabotropic glutamate receptors and G-proteins in rat cerebral cortex assessed by guanosine-5'-O-(3-[(35)S]thio)triphosphate binding assay.
Odagaki Y; Kinoshita M; Toyoshima R
Basic Clin Pharmacol Toxicol; 2011 Sep; 109(3):175-85. PubMed ID: 21443596
[TBL] [Abstract][Full Text] [Related]
26. The putative <> 5-HT(1A) receptor antagonist, WAY 100635, has inverse agonist properties at cloned human 5-HT(1A) receptors.
Cosi C; Koek W
Eur J Pharmacol; 2000 Jul; 401(1):9-15. PubMed ID: 10915831
[TBL] [Abstract][Full Text] [Related]
27. Measurement of agonist-stimulated [35S]GTPgammaS binding to assess total G-protein and Galpha-subtype-specific activation by G-protein-coupled receptors.
Dowling MR; Nahorski SR; Challiss RA
Methods Mol Biol; 2004; 259():197-206. PubMed ID: 15250494
[TBL] [Abstract][Full Text] [Related]
28. Activation of guanosine 5'-[gamma-(35)S]thio-triphosphate binding through M(1) muscarinic receptors in transfected Chinese hamster ovary cell membranes; 1. Mathematical analysis of catalytic G protein activation.
Waelbroeck M
Mol Pharmacol; 2001 Apr; 59(4):875-85. PubMed ID: 11259633
[TBL] [Abstract][Full Text] [Related]
29. Inverse agonism and constitutive activity as functional correlates of serotonin h5-HT(1B) receptor/G-protein stoichiometry.
Newman-Tancredi A; Audinot V; Moreira C; Verrièle L; Millan MJ
Mol Pharmacol; 2000 Nov; 58(5):1042-9. PubMed ID: 11040052
[TBL] [Abstract][Full Text] [Related]
30. Absence of G-protein activation by mu-opioid receptor agonists in the spinal cord of mu-opioid receptor knockout mice.
Narita M; Mizoguchi H; Narita M; Sora I; Uhl GR; Tseng LF
Br J Pharmacol; 1999 Jan; 126(2):451-6. PubMed ID: 10077238
[TBL] [Abstract][Full Text] [Related]
31. Comparison of [Dmt1]DALDA and DAMGO in binding and G protein activation at mu, delta, and kappa opioid receptors.
Zhao GM; Qian X; Schiller PW; Szeto HH
J Pharmacol Exp Ther; 2003 Dec; 307(3):947-54. PubMed ID: 14534366
[TBL] [Abstract][Full Text] [Related]
32. G protein activation by human dopamine D3 receptors in high-expressing Chinese hamster ovary cells: A guanosine-5'-O-(3-[35S]thio)- triphosphate binding and antibody study.
Newman-Tancredi A; Cussac D; Audinot V; Pasteau V; Gavaudan S; Millan MJ
Mol Pharmacol; 1999 Mar; 55(3):564-74. PubMed ID: 10051542
[TBL] [Abstract][Full Text] [Related]
33. Identification of a unique membrane receptor for adenosine 5',5"'-P1,P4-tetraphosphate.
Hilderman RH; Martin M; Zimmerman JK; Pivorun EB
J Biol Chem; 1991 Apr; 266(11):6915-8. PubMed ID: 2016305
[TBL] [Abstract][Full Text] [Related]
34. Radioligand assays for oestradiol and progesterone conjugated to protein reveal evidence for a common membrane binding site in the medial preoptic area-anterior hypothalamus and differential modulation by cholera toxin and GTPgammaS.
Caldwell JD; Walker CH; Rivkina A; Pedersen CA; Mason GA
J Neuroendocrinol; 1999 Jun; 11(6):409-17. PubMed ID: 10336721
[TBL] [Abstract][Full Text] [Related]
35. Fish somatostatin sst3 receptor: comparison of radioligand and GTPgammaS binding, adenylate cyclase and phospholipase C activities reveals different agonist-dependent pharmacological signatures.
Siehler S; Nunn C; Zupanc GK; Hoyer D
Auton Autacoid Pharmacol; 2005 Jan; 25(1):1-16. PubMed ID: 15659149
[TBL] [Abstract][Full Text] [Related]
36. Ecto-enzymatic hydrolysis of diadenosine polyphosphates by cultured adrenomedullary vascular endothelial cells.
Mateo J; Miras-Portugal MT; Rotllán P
Am J Physiol; 1997 Sep; 273(3 Pt 1):C918-27. PubMed ID: 9316413
[TBL] [Abstract][Full Text] [Related]
37. In vitro autoradiography of serotonin 5-HT(2A/2C) receptor-activated G protein: guanosine-5'-(gamma-[(35)S]thio)triphosphate binding in rat brain.
Adlersberg M; Arango V; Hsiung S; Mann JJ; Underwood MD; Liu K; Kassir SA; Ruggiero DA; Tamir H
J Neurosci Res; 2000 Sep; 61(6):674-85. PubMed ID: 10972964
[TBL] [Abstract][Full Text] [Related]
38. Alteration of hemoglobin function by diadenosine 5',5'''-P1,P4-tetraphosphate and other alarmones.
Bonaventura C; Cashon R; Colacino JM; Hilderman RH
J Biol Chem; 1992 Mar; 267(7):4652-7. PubMed ID: 1537848
[TBL] [Abstract][Full Text] [Related]
39. P2 purinergic receptors for diadenosine polyphosphates in the nervous system.
Pintor J; Miras-Portugal MT
Gen Pharmacol; 1995 Mar; 26(2):229-35. PubMed ID: 7590071
[TBL] [Abstract][Full Text] [Related]
40. Nucleoside diphosphate kinase associated with membranes modulates mu-opioid receptor-mediated [35S]GTPgammaS binding and agonist binding to mu-opioid receptor.
Zhang D; Li JG; Chen C; Liu-Chen LY
Eur J Pharmacol; 1999 Jul; 377(2-3):223-31. PubMed ID: 10456435
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
